In prostate cancer, integrative genomic analyses of prostate tumors identified that amplification of ESRP1 is associated with early-onset aggressive prostate cancer and high ESRP1 expression correlates with a more proliferative gene expression profile [57]. This evidence concerns the gene ESRP1 and prostate carcinoma.